Negar Niknam
Gastroenterology · Tampa, FLNPI 1922400092
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.2% of the total across 94 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 24 manufacturers reported payments, led by AbbVie at 27.4% of the total.
Across 94 payments — averaging $48.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Boston Scientific$710
- Gilead$376
- Abbott$275
- Amgen$250
- Corcept Therapeutics$203
- plus $2K from 18 others
What the payments were for
- Travel & lodging$2205%
- Food & beverage$4,34795%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 35 | $1,252 |
| Boston Scientific | 12 | $710 |
| Gilead | 10 | $376 |
| Abbott | 2 | $275 |
| Amgen | 2 | $250 |
| Corcept Therapeutics | 1 | $203 |
| Daiichi Sankyo Inc. | 4 | $195 |
| Celltrion USA Inc. | 6 | $161 |
| Steris Corporation | 1 | $138 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $135 |
| Olympus America Inc. | 2 | $129 |
| Edwards Lifesciences | 1 | $129 |
| Ascendis Pharma Endocrinology Inc | 1 | $125 |
| Phathom Pharmaceuticals, Inc. | 1 | $125 |
| Madrigal Pharmaceuticals | 3 | $109 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $50 |
| Johnson & Johnson(2 entities) | 2 | $46 |
| Covidien LP | 1 | $38 |
| Pfizer | 1 | $30 |
| AstraZeneca | 1 | $24 |
| Merck | 1 | $22 |
| W. L. Gore & Associates, Inc. | 1 | $17 |
| Micro-tech Endoscopy USA, Inc. | 1 | $14 |
| Redhill Biopharma Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- RAYOS$375
- FREESTYLE LIBRE 3$275
- GENERAL - BILIARY DEVICES$230
- Korlym$203
- ORISE$166
- Creon$150
- INFINITY$138
- TRUFREEZE$138
- Assurance$138
- Padlock Clip$138
- TEPEZZA$125
- Yorvipath$125
- VOQUEZNA$125
- CYCLOSET$125
- INJECTAFER$124
- Humira$124
- VRAYLAR$110
- Olympus Endoscopic Ultrasound Scopes$104
How this compares
$4,566 in reported general payments places this provider in the 60th percentile of 1,388 gastroenterology providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pantoprazole Sodium | 23 | $216 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 14 | $177 |
| Famotidine | 14 | $101 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Tampa
- Adnan MuhammadTampa$150K
- John JacobsTampa$141K
- Renee Marchioni BeeryTampa$126K
- Michael DanielTampa$52K
- Samuel GidayOrlando$2M
- Lukasz KwapiszMiami$1.2M
- Jennifer Seminerio-DiehlOrlando$1.1M
- Udayakumar NavaneethanSaint Petersburg$1.1M
- Ronen AraiCoral Springs$1.1M
- Charles SninskyGainesville$983K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.